Complete and near complete responses (morphologic leukemia-free state) observed with OmnImmune® starting at lowest dose level in Phase 1b/2a study for the treatment of relapsed/refractory acute myeloid leukemia
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”